These drugs ability to help patients lose anywhere from 15% to 20% of body weight has made them one of the most powerful nonsurgical obesity treatments ever seen
Initial assessment (Day 1) Comprehensive medical history, including screening for contraindications (medullary thyroid cancer history, MEN2, pancreatitis, severe gastroparesis, pregnancy planning) Physical examination, BMI and body composition analysis Comprehensive metabolic bloodwork: HbA1c, fasting glucose, lipid panel, liver function, kidney function, TSH, vitamin D, B12, ferritin Medication selection discussion based on clinical profile, goals, availability, and budget Baseline measurements and photography for progress tracking The initial consultation is conducted by Dr Ary Wulandari Sp.D.V.E, Dr Andrew Uidjaja M
GHK-Cu is a naturally occurring copper-binding peptide commonly discussed in skin, hair, and tissue-repair research
Hamlet Gasoyan, PhD, the lead author of the study and a researcher with Cleveland Clinics Center for Value-Based Care Research, set out to explore whether patients were willing to stick with these prescriptions to treat their obesity
It has clear efficacy data
